Example: Heart Attack

Search clinical trials for: Glipizide

Total 31 results

NCT02911792

Recruiting

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Conditions: Diabetes Mellitus, Type 2
NCT04167761

Not yet recruiting

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Conditions: Cardiovascular Diseases, Atherosclerosis, Type 2 Diabetes, Insulin Resistance
NCT02608177

Completed

Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management

Conditions: Chronic Kidney Diseases, Type 2 Diabetes
NCT01698775

Completed

A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Conditions: Type 2 Diabetes Mellitus
NCT00885352

Completed

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

Conditions: Type 2 Diabetes Mellitus
NCT00509262

Completed

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Conditions: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic
NCT00509236

Completed

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Conditions: Diabetes Mellitus, Type 2, End-Stage Kidney Disease
NCT00350779

Completed

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Conditions: Type 2 Diabetes Mellitus
NCT00086515

Completed

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Conditions: Diabetes Mellitus, Type II
NCT00947024

Completed

To Demonstrate the Effect of Food on the Bioavailability of Glipizide

Conditions: Type 2 Diabetes
NCT00946504

Completed

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

Conditions: Type 2 Diabetes
NCT00116831

Completed

Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

Conditions: Atherosclerosis
NCT01762046

Unknown status

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

Conditions: Diabetes Mellitus, Type 2
NCT00094770

Completed

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

Conditions: Diabetes Mellitus, Type 2
NCT01951651

Completed

Effect of Exenatide on Liver and Heart Fat and Inflammation

Conditions: Type 2 Diabetes Mellitus
NCT00095056

Completed

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

Conditions: Diabetes Mellitus, Type 2, Chronic Renal Insufficiency
NCT00660907

Completed

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Conditions: Type 2 Diabetes
NCT00856284

Completed

Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT00707993

Completed

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Conditions: Diabetes Mellitus
NCT01758471

Unknown status

Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT01020123

Completed

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Conditions: Type II Diabetes Mellitus
NCT00513630

Completed

Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease

Conditions: Type 2 Diabetes, Coronary Artery Disease
NCT01267448

Unknown status

Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia

Conditions: Diabetes Mellitus Type 2, Severe Hyperglycemia - Blood Glucose Level >300mg/dl.
NCT01082796

Completed

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

Conditions: Genotype, Pharmacokinetic
NCT00835497

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting

Conditions: Healthy